QC
ROIV icon

Quent Capital’s Roivant Sciences ROIV Stock Holding History

Quent Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.82K Sell
221
-3,909
-95% -$116K ﹤0.01% 1294
2026
Q1 		$114K Buy
4,130
+4,028
+3,949% +$103K 0.01% 510
2025
Q4 		$2.21K Hold
102
– – ﹤0.01% 1388
2025
Q3 		$1.54K Buy
+102
New +$1.26K ﹤0.01% 1286
2025
Q2 		– Sell
-102
Closed -$1.03K – 1045
2025
Q1 		$1.03K Sell
102
-20
-16% -$216 ﹤0.01% 1209
2024
Q4 		$1.44K Sell
122
-78
-39% -$922 ﹤0.01% 1205
2024
Q3 		$2.31K Hold
200
– – ﹤0.01% 1208
2024
Q2 		$2.11K Buy
200
+42
+27% +$460 ﹤0.01% 1207
2024
Q1 		$1.67K Buy
158
+156
+7,800% +$1.68K ﹤0.01% 1250
2023
Q4 		$22 Buy
+2
New +$19 ﹤0.01% 1324

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Quent Capital's ROIV Position: Q2 2026 in Review

Quent Capital reduced its Roivant Sciences (ROIV) stake by 95% in Q2 2026, selling an estimated $116K and leaving 221 shares worth $7.82K. The position accounts for ﹤0.01% of the portfolio, ranked #1294.

Quent Capital first reported a position in ROIV in Q4 2023 and has held it in 10 quarters since. The position peaked at $114K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Quent Capital held 221 shares of Roivant Sciences worth $7.82K as of Q2 2026.
  • Quent Capital sold 3,909 Roivant Sciences shares in Q2 2026, an estimated $116K.
  • Roivant Sciences made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1294 holding.
  • Quent Capital first reported a position in Roivant Sciences in Q4 2023 and has held it in 10 quarters since.
  • Quent Capital's Roivant Sciences position peaked at $114K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.